Singapore markets open in 36 minutes

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.2669+0.0151 (+6.00%)
At close: 04:00PM EDT
0.2702 +0.00 (+1.24%)
After hours: 07:49PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
233.881
881.705
3,937
36,144
4,822
Operating expenses
Research development
29,011
36,445
98,267
89,605
48,614
Selling general and administrative
20,315
20,425
28,480
23,643
12,956
Total operating expenses
49,326
56,871
126,747
113,248
61,570
Operating income or loss
-49,092
-55,989
-122,810
-77,105
-56,748
Total other income/expenses net
11,722
12,179
12,569
4,423
92.791
Income before tax
-39,012
-45,640
-111,269
-71,454
-55,672
Income from continuing operations
-39,012
-45,640
-111,269
-71,454
-55,672
Net income
-39,012
-45,640
-111,269
-71,454
-55,672
Net income available to common shareholders
-39,012
-45,640
-111,269
-71,454
-55,672
Basic EPS
-
-0.37
-1.42
-1.12
-0.98
Diluted EPS
-
-0.37
-1.42
-1.12
-0.98
Basic average shares
-
122,990
78,133
63,899
57,000
Diluted average shares
-
122,990
78,133
63,899
57,000
EBITDA
-
-54,350
-121,116
-75,875
-56,254